MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01954nam a2200277Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230724s2002 xx 000 0 und d |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
|
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Aliot, E. |
| 9 (RLIN) |
7823 |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Ventricular instability and sudden death in patients with heart failure : |
| Remainder of title |
lessons from clinical trials / |
| Statement of responsibility, etc. |
E. Aliot, C. de Chillou, N. Sadoul |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc. |
April 2002 |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE |
|---|
| Number of part/section of a work |
4 : Supplement D, pages D31-D42 |
| Title |
European Heart Journal Supplements |
| 9 (RLIN) |
7824 |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Various trials using non-antiarrhythmic drugs, antiarrhythmic agents and implantable-cardioverter defibrillators (ICDs) have been performed in order to decrease the incidence of sudden death and to improve survival in chronic heart failure (CHF). The present review addresses some of the key findings of those trials. First, it addresses the importance of considering the potential electrophysiological effects of non-antiarrhythmic drugs and of using angiotensin-converting enzyme inhibitors, beta-blockers and antialdosterone agents in the optimal management of patients with CHF. Second, it reviews the effects of the antiarrhythmic agent amiodarone on mortality and arrhythmic deaths in patients with depressed left ventricular function. Third, it assesses the evidence that patients with CHF and a history of sustained ventricular arrhythmias or resuscitation may benefit from ICD implantation. Finally, it outlines the growing role of ICD therapy in patients with CHF as a primary indication. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
Nursing. |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Amiodarone. |
| 9 (RLIN) |
7825 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Angiotensin-converting enzyme inhibitors. |
| 9 (RLIN) |
7826 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Antiarrhythmic drugs. |
| 9 (RLIN) |
7827 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Beta-blockers. |
| 9 (RLIN) |
7828 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Congestive heart failure. |
| 9 (RLIN) |
7829 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Implantable cardioverter-defibrillator. |
| 9 (RLIN) |
7830 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Sudden death. |
| 9 (RLIN) |
7831 |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Ventricular arrythmias. |
| 9 (RLIN) |
7832 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
Articles |
